A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics After Oral Administration of DW1903, DW1903-R1 and DW1903-R2 in Healthy Adult Volunteers
Latest Information Update: 02 May 2023
At a glance
- Drugs Esomeprazole (Primary) ; Famotidine
- Indications Gastritis
- Focus Pharmacodynamics
- Sponsors Daewon Pharmaceutical
- 02 May 2023 New trial record
- 24 Mar 2023 Results (n=26) presented at the 124th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics